Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Sarcoma, Synovial 1Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rhabdomyosarcoma 1Ovarian Neoplasms 1Neurofibrosarcoma 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1

Interventions

Doxorubicin 4Ifosfamide 3Radiotherapy 2Ipilimumab 2Filgrastim 2saracatinib 1perifosine 1pembrolizumab 1fludarabine 1brostallicin 1belinostat 1aldesleukin 1Trabectedin 1Temozolomide 1Sunitinib 1Ritonavir 1Nivolumab 1Mass Spectrometry 1Injections 1Indinavir 1Imatinib Mesylate 1Fluorouracil 1Cyclophosphamide 1Chromatography, High Pressure Liquid 1Chemotherapy, Adjuvant 1CTLA-4 Antigen 1BI 2536 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytoma, Malignant Fibrous × perifosine × Gynecologic × Clear all
NCT00053794 2023-08-04

Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma

Canadian Cancer Trials Group

Phase 2 Completed
17 enrolled
GynecologicSarcoma

Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡